5
PUREGRAFT ® Comparison of Three Fat Graſt Preparation Methods: Gravity Separation, Centrifugation, and the Cytori Puregraſt ® System John K. Fraser Ph.D., Min Zhu M.D., Douglas M. Arm Ph.D., Johnson C. Yu RATIONALE Autologous fat graſting is increasingly being used in various clinical applications. 1-3 Physicians are aware that long-term graſt retention is affected by different graſt tissue preparation techniques. 4 One goal of these techniques is to remove contaminants, such as free lipids released by ruptured adipocytes, red blood cells, and leukocytes, each of which can negatively impact graſt retention and exacerbate an inflammatory response. In addition, these techniques serve to remove excess tumescent fluid, which merely dilutes the graſt tissue. Thus, physicians need techniques that remove unwanted contaminants and reduce the aqueous liquid component of the graſt while maintaining desirable handling characteristics (e.g., viscosity). The three most common preparation techniques described in the literature are gravity separation alone (which requires the least user handling and manipulation), centrifugation, and washing of the fat graſt prior to gravity separation. 4 Each of these approaches has inherent advantages and disadvantages in terms of complexity, graſt preparation time, and the residual content of contaminants and aqueous liquid. In the current study, we performed a side-by- side comparison of graſt washing using the Cytori Therapeutics Inc. Puregraſt system, centrifugation, and separation by gravity. Contents were examined for free lipids, aqueous liquid, and blood cells. METHODS Adipose tissue from 14 different female donors was acquired from subcutaneous abdomen, flank, thigh, and back adipose tissue deposits using vacuum-assisted suction (n=7), laser- based “liposculpturing” (n=5), and water- assisted liposuction (n=2). Tissue from each donor was divided into four groups for processing by different methods: control (equivalent to a surgeon aspirating and immediately using tissue for autograſting), gravity separation, traditional centrifugation, and washing in a Puregraſt system. Control samples were analyzed without further manipulation. Gravity separation samples were kept in a 60 mL syringe for 10 minutes, aſter which the infranatant, largely comprising tumescent solution and blood, was removed prior to further testing. Centrifugation samples were loaded into a capped 10 mL syringe, placed into an IEC fixed angle rotor centrifuge and centrifuged at 3000 rpm (~1,200 x g) for three minutes. Free lipids floating above the adipose tissue were removed by aspiration and the infranatant drained. Puregraſt samples were prepared using the Cytori Puregraſt 250 system with two washing steps. Each prepared graſt sample is comprised of four components: adipose tissue, aqueous liquid (residual tumescent solution or wash solution), free lipids released from ruptured adipocytes or adipocyte lipolysis, and a nonbuoyant component comprised of blood cells and tissue fragments. In order to evaluate the contribution of each component to the volume of the graſt as a whole,

Comparison of Three Fat Graft Preparation Methods: Gravity ...trianglesurgical.uk/wp-content/uploads/2014/03/RM... · methods. This figure shows examples of grafts prepared by (from

  • Upload
    others

  • View
    0

  • Download
    0

Embed Size (px)

Citation preview

Page 1: Comparison of Three Fat Graft Preparation Methods: Gravity ...trianglesurgical.uk/wp-content/uploads/2014/03/RM... · methods. This figure shows examples of grafts prepared by (from

PUREGRAFT ®

Comparison of Three Fat Graft Preparation Methods: Gravity Separation, Centrifugation, and the Cytori Puregraft® SystemJohn K. Fraser Ph.D., Min Zhu M.D., Douglas M. Arm Ph.D., Johnson C. Yu

RATIONALE

Autologous fat grafting is increasingly being used in various clinical applications.1-3 Physicians are aware that long-term graft retention is affected by different graft tissue preparation techniques.4 One goal of these techniques is to remove contaminants, such as free lipids released by ruptured adipocytes, red blood cells, and leukocytes, each of which can negatively impact graft retention and exacerbate an inflammatory response. In addition, these techniques serve to remove excess tumescent fluid, which merely dilutes the graft tissue. Thus, physicians need techniques that remove unwanted contaminants and reduce the aqueous liquid component of the graft while maintaining desirable handling characteristics (e.g., viscosity).

The three most common preparation techniques described in the literature are gravity separation alone (which requires the least user handling and manipulation), centrifugation, and washing of the fat graft prior to gravity separation.4 Each of these approaches has inherent advantages and disadvantages in terms of complexity, graft preparation time, and the residual content of contaminants and aqueous liquid.

In the current study, we performed a side-by-side comparison of graft washing using the Cytori Therapeutics Inc. Puregraft system, centrifugation, and separation by gravity. Contents were examined for free lipids, aqueous liquid, and blood cells.

METHODS

Adipose tissue from 14 different female donors was acquired from subcutaneous abdomen, flank, thigh, and back adipose tissue deposits using vacuum-assisted suction (n=7), laser-based “liposculpturing” (n=5), and water-assisted liposuction (n=2). Tissue from each donor was divided into four groups for processing by different methods: control (equivalent to a surgeon aspirating and immediately using tissue for autografting), gravity separation, traditional centrifugation, and washing in a Puregraft system. Control samples were analyzed without further manipulation. Gravity separation samples were kept in a 60 mL syringe for 10 minutes, after which the infranatant, largely comprising tumescent solution and blood, was removed prior to further testing. Centrifugation samples were loaded into a capped 10 mL syringe, placed into an IEC fixed angle rotor centrifuge and centrifuged at 3000 rpm (~1,200 x g) for three minutes. Free lipids floating above the adipose tissue were removed by aspiration and the infranatant drained. Puregraft samples were prepared using the Cytori Puregraft 250 system with two washing steps.

Each prepared graft sample is comprised of four components: adipose tissue, aqueous liquid (residual tumescent solution or wash solution), free lipids released from ruptured adipocytes or adipocyte lipolysis, and a nonbuoyant component comprised of blood cells and tissue fragments. In order to evaluate the contribution of each component to the volume of the graft as a whole,

Page 2: Comparison of Three Fat Graft Preparation Methods: Gravity ...trianglesurgical.uk/wp-content/uploads/2014/03/RM... · methods. This figure shows examples of grafts prepared by (from

Comparison of Three Fat Graft Preparation Methods

triplicate 10 mL samples were prepared for each group from each donor. Tissue was transferred to 15 mL centrifuge tubes (Falcon) and processed by centrifugation at 400 x g for five minutes at room temperature in order to separate the graft into four components. The volume of each component was determined and recorded as a percentage of the graft as a whole. The cellular pellet was then retrieved and resuspended in order to permit quantification of red and white blood cells using a Coulter Hematology Analyzer (Beckman Coulter Model AC.T10). Results of cell counts were averaged and expressed as a percentage of the control group on the basis of cells per gram of graft. One-way ANOVA analysis was used to assess differences between the four graft preparation methods. Samples from each group were also spread on a microscope slide and examined for the presence of contaminants, such as free lipids and blood cells.

GRAFT APPEARANCE RESULTS

Representative examples of grafts prepared by each of the four approaches are provided in Figure 1. The appearance of the tissue suggests least contamination by red blood cells in the grafts prepared within the Puregraft product. This

observation is supported by the size of the cell pellet obtained following centrifugation of each graft (Figure 2).

HISTOLOGY

Aliquots of graft tissue prepared by each method were also investigated under a microscope. Representative images are shown in Figure 3. The images further confirmed the graft appearance we observed. Minimal oil droplets and blood cells were observed in grafts prepared by the Puregraft system, while noticeable amounts of small lipid particles and red blood cells were viewed in the grafts prepared by other methods.

AQUEOUS LIQUID CONTENT:

The aqueous liquid content of grafts prepared using the different preparation methods can be seen for one representative sample in Figure 2. The numerical data of all samples was presented as average percentage of the total graft (Table 1). Compared to unmanipulated control samples (33.21 ± 1.8%) and the samples prepared by gravity separation (24.5 ± 1.4%), the graft tissues prepared by centrifugation and Puregraft

2

Figure 1. Graft tissue prepared by different methods. This figure shows examples of grafts prepared by (from left to right): control, gravity separation, centrifugation, and Puregraft 250 preparation. Figure 2. Graft tissue prepared by different methods. This figure shows examples of grafts prepared by (from left to right): control, gravity separation, centrifugation, and Puregraft 250 preparation. This image was taken after the final 400g centrifugation separated the prepared grafts into their four phase components: cell pellet (bottom),aqueous liquid, adipose tissue, and free lipids (top).

Figure 1. Figure 2.

CONTROL CONTROLGRAVITY SEPARATION GRAVITY SEPARATIONCENTRIFUGATION CENTRIFUGATIONPUREGRAFT 250 PUREGRAFT 250

Lipid

AqueousLiquid

Pellet

Tissue

Page 3: Comparison of Three Fat Graft Preparation Methods: Gravity ...trianglesurgical.uk/wp-content/uploads/2014/03/RM... · methods. This figure shows examples of grafts prepared by (from

Comparison of Three Fat Graft Preparation Methods

contained significantly less liquid (p<0.001 for all comparisons). The mean liquid content of tissue prepared using Puregraft was 8.1 ± 0.9%, which was comparable to that of graft tissue prepared by centrifugation (5.2 ± 0.5%). In addition, the fluid content in grafts prepared by the Puregraft system may be adjusted to a wider range (from 2.67% to 20%), depending on the drain time and drain techniques (active or passive) used. Thus, physicians can control the graft viscosity to their desired consistency.

FREE LIPID CONTENT

The amount of free lipids present in graft tissue directly indicates that fat cell disruption has occurred during tissue collection and processing,

and indirectly reflects the overall health of the processed tissue. Graft tissue prepared using the Cytori Puregraft system contained significantly fewer free lipids than grafts prepared with any other method (Figure 4). The residual free lipid level in the Puregraft samples averaged 0.8 ± 0.3%, significantly less than the control (unmanipulated) tissue (10.5 ±1.7%, p<0.001). Tissue prepared by gravity separation (8.7 ± 1.7%, p<0.001), or centrifuged tissue (10.2 ± 1.5%, p<0.001).

BLOOD CELL CONTENT

The data shown in Figures 1 and 2 suggest that grafts prepared using Puregraft contain less contamination by blood cells than those prepared

3

Figure 4. Graft free lipid content after preparation using the four methods (N=14). Grafts prepared by Puregraft 250 contained significantly less free lipid than those prepared by the other three methods (p<0.001).

Figure 3. Graft tissue prepared by different methods. This figure shows examples of grafts prepared by (from left to right): gravity separation, centrifugation, and Puregraft 250 System preparation. Circles highlight red blood cell clusters and arrows indicate free lipids.

Gravity Separation Centrifugation Puregraft®

Perc

enta

ge o

f Lip

id C

onte

nt (

%)

Control Gravity Centrifuga�on Puregra�®

Lipid Content within Gra�

Different Gra� Prepara�on Methods

14

12

10

8

6

4

2

0

Different Graft Preparation Methods

Percentage of Fluid Content (Range)

User Control of Fluid Content

Control 23.3-45.8% No

Gravity 18.3-36.7% No

Centrifugation 2.0-7.7% No

Puregraft® 2.7-20% as controlled by user

Yes

Table 1: Fluid Content within Grafts

Page 4: Comparison of Three Fat Graft Preparation Methods: Gravity ...trianglesurgical.uk/wp-content/uploads/2014/03/RM... · methods. This figure shows examples of grafts prepared by (from

Comparison of Three Fat Graft Preparation Methods

by the other methods. This parameter was analyzed further by collecting the cell pellets, resuspending them in buffer, and performing cell counts using a Hematology Analyzer. The data confirms that graft prepared with Puregraft contained significantly fewer white and red blood cells than grafts prepared using the other methods (Table 2). While gravity separation and centrifugation remove approximately 50% of red blood cells and 60-70% of white blood cells, preparation with Puregraft removed more than 95% of both white and red blood cells.

GRAFT YIELD

Physicians are also concerned about the effect of the preparation method on graft yield. Control tissue contained tumescent fluid and free lipids; the actual tissue was 63.96 ± 2.96% of the harvested lipoaspirate. After preparation, centrifugation retained 51.71 ± 4.91% of the tissue and Puregraft retained 51.95 ± 5.95% of tissue (Figure 5). Therefore, Puregraft produced actual graft tissue yields comparable to traditional centrifugation.

CONCLUSION

For all parameters tested, the Puregraft system performed as well as, or better than, other commonly used preparation methods. Relative performance of the preparation methods was consistent across all 14 samples.

The volume of graft tissue yield recovered by either centrifugation or Puregraft is comparable (Figure 5). The Puregraft system also generates graft tissue with comparable fluid content to traditional centrifugation. Unlike traditional centrifugation, the Puregraft system allows clinicians to control the fluid content of graft tissue (Table 1). Physicians can control graft tissue hydration, and therefore consistency, by adjusting drain time and drain techniques.

As shown in Figures 1 and 2, the gross appearance of tissue processed with Puregraft is cleaner, with evidence of significantly fewer free lipids and blood cells than grafts prepared by either centrifugation or gravity separation. It is important to note that the free lipid content of grafts prepared by centrifugation was measured after removal of the free lipids observed during the actual preparation of the graft. That is, the free lipid evident in Figure 2 and quantified in Figure 4 (average 9.6% of graft volume) was newly released. This indicates that the graft material

4

Figure 5. Yield of graft tissue prepared by different methods (N=5). Controls were sampled before processing. Percentages of graft tissue remaining after processing by centrifugation and the Puregraft method were normalized to that of control tissue.

Puregra�®

Graft Prepa-ration

Red Blood Cells (N=12)

White Blood Cells (N=8)

p value vs Puregraft®

Puregraft 1.93 ± 0.3% 2.87 ± 0.61% ----------

Gravity 53.52 ± 5.2% 41.3 ± 10.5% RBC, WBC <0.001

Centrifuge 47.6 ± 5.1% 32.4 ± 4.6% RBC, WBC <0.001

* Values are normalized to the mean negative control samples for each donor tissue. Results demonstrate that grafts prepared using Puregraft 250 contain significantly less blood than grafts from other preparation methods.

Table 2: Blood Cell Content of Graft Tissue

Page 5: Comparison of Three Fat Graft Preparation Methods: Gravity ...trianglesurgical.uk/wp-content/uploads/2014/03/RM... · methods. This figure shows examples of grafts prepared by (from

Comparison of Three Fat Graft Preparation Methods

contained damaged adipocytes that released their lipid during the second centrifugation applied to separate the graft into its four component parts. The fact that grafts prepared within Puregraft contained markedly fewer free lipids following the same centrifugation suggests that Puregraft samples contain fewer damaged adipocytes.

Fat grafts prepared using the Cytori Puregraft system appear to be less damaged and less bloody than grafts prepared by either gravity separation

or centrifugation. In addition, Puregraft is a

closed system that remains on the sterile field

and provides a rapid (~15 minutes) means of

preparing lipoaspirate for autologous fat grafting.

breast reconstruction procedure requires less

time in the operating theatre as compared to for

example a flap procedure and shows significant

improvements in repair to the skin and breast

tissue and restoration of natural looking breasts

with minimal scarring.

5

REFERENCES(1) Delay E, Garson S, Tousson G, Sinna R. Fat injection to the breast: technique, results, and indications based on 880 procedures

over 10 years. Aesthet Surg J. 2009;29:360-376.

(2) Kaufman MR, Miller TA, Huang C et al. Autologous fat transfer for facial recontouring: is there science behind the art? Plast Reconstr Surg. 2007;119:2287-2296.

(3) Yamamoto T, Gotoh M, Hattori R et al. Periurethral injection of autologous adipose-derived stem cells for the treatment of stress urinary incontinence in patients undergoing radical prostatectomy: Report of two initial cases. Int J Urol. 2009.

(4) Kaufman MR, Bradley JP, Dickinson B et al. Autologous fat transfer national consensus survey: trends in techniques for harvest, preparation, and application, and perception of short- and long-term results. Plast Reconstr Surg. 2007;119:323-331.

CUSTOMER SERVICE

EU/Middle East: +41.41.375.375.0 USA: +1.858.875.5245 Japan: +81.3.5223.6500 India: [email protected]

Cytori Therapeutics, Inc.

3020 Callan RoadSan Diego, CA 92121, USATel: +1.858.458.0900 Fax: +1.858.875.5065cytori.com

RM-034-LIT-USEU_C-0613

This document is for informational purposes only. The information contained in this document was selected from public sources that Cytori believes are reasonable. This document represents Cytori’s current opinions on the issues discussed as of the date of publication and are subject to change without notice. Cytori accepts no responsibility for any liability arising from use of this document or its contents.

Puregraft is a registered trademark of Cytori Therapeutics, Inc.

© 2013 Cytori Therapeutics, Inc. All rights reserved.